Drucker Wealth 3.0 LLC Raises Stock Holdings in Bath & Body Works, Inc. $BBWI

Drucker Wealth 3.0 LLC grew its position in shares of Bath & Body Works, Inc. (NYSE:BBWI) by 133.5% in the first quarter, according to its most recent filing with the SEC. The fund owned 52,857 shares of the company’s stock after acquiring an additional 30,217 shares during the quarter. Drucker Wealth 3.0 LLC’s holdings in Bath & Body Works were worth $987,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds have also recently modified their holdings of the company. Global Retirement Partners LLC purchased a new stake in Bath & Body Works during the fourth quarter valued at $31,000. Activest Wealth Management purchased a new position in shares of Bath & Body Works in the 4th quarter worth $32,000. Geneos Wealth Management Inc. increased its holdings in shares of Bath & Body Works by 217.7% in the 1st quarter. Geneos Wealth Management Inc. now owns 1,169 shares of the company’s stock worth $35,000 after buying an additional 801 shares during the last quarter. Parallel Advisors LLC increased its holdings in shares of Bath & Body Works by 42.6% in the 4th quarter. Parallel Advisors LLC now owns 1,897 shares of the company’s stock worth $38,000 after buying an additional 567 shares during the last quarter. Finally, Danske Bank A S bought a new stake in shares of Bath & Body Works in the 3rd quarter worth about $39,000. 95.14% of the stock is owned by hedge funds and other institutional investors.

Bath & Body Works Trading Up 2.9%

Bath & Body Works stock opened at $23.51 on Tuesday. The firm has a 50-day moving average price of $19.25 and a 200-day moving average price of $20.32. The firm has a market capitalization of $4.74 billion, a PE ratio of 6.61, a price-to-earnings-growth ratio of 2.27 and a beta of 1.42. Bath & Body Works, Inc. has a 12-month low of $14.27 and a 12-month high of $33.96.

Bath & Body Works (NYSE:BBWI) last released its quarterly earnings results on Wednesday, May 27th. The company reported $0.32 EPS for the quarter, topping analysts’ consensus estimates of $0.29 by $0.03. Bath & Body Works had a net margin of 10.03% and a negative return on equity of 45.34%. The firm had revenue of $1.38 billion during the quarter, compared to analysts’ expectations of $1.36 billion. During the same period in the previous year, the company earned $0.49 EPS. The firm’s revenue for the quarter was down 3.2% compared to the same quarter last year. Bath & Body Works has set its Q2 2026 guidance at 0.300-0.300 EPS and its FY 2026 guidance at 2.400-2.650 EPS. As a group, sell-side analysts predict that Bath & Body Works, Inc. will post 2.62 earnings per share for the current fiscal year.

Bath & Body Works Dividend Announcement

The firm also recently announced a quarterly dividend, which was paid on Friday, June 19th. Stockholders of record on Friday, June 5th were paid a dividend of $0.20 per share. The ex-dividend date of this dividend was Friday, June 5th. This represents a $0.80 dividend on an annualized basis and a dividend yield of 3.4%. Bath & Body Works’s dividend payout ratio is currently 22.47%.

Analysts Set New Price Targets

A number of research analysts recently commented on BBWI shares. Weiss Ratings downgraded shares of Bath & Body Works from a “hold (c-)” rating to a “sell (d+)” rating in a report on Tuesday, June 2nd. UBS Group reduced their price objective on Bath & Body Works from $22.00 to $19.00 and set a “neutral” rating on the stock in a research note on Wednesday, May 20th. Deutsche Bank Aktiengesellschaft boosted their price objective on Bath & Body Works from $21.00 to $22.00 and gave the stock a “hold” rating in a research note on Tuesday, March 3rd. Barclays lowered their price objective on Bath & Body Works from $25.00 to $23.00 and set an “equal weight” rating for the company in a research note on Thursday, May 28th. Finally, Raymond James Financial reiterated a “market perform” rating on shares of Bath & Body Works in a report on Wednesday, May 27th. Three analysts have rated the stock with a Buy rating, fourteen have assigned a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat, Bath & Body Works has an average rating of “Hold” and a consensus price target of $22.00.

Bath & Body Works Company Profile

Bath & Body Works, Inc is a leading specialty retailer focused on personal care, home fragrance and complementary products. Through its flagship Bath & Body Works brand, the company offers a diverse assortment of shower gels, lotions, fragrance mists, candles and home fragrance items. Its product portfolio also includes the White Barn Candle Co range of premium scented candles and diffusers. Bath & Body Works serves consumers through a combination of brick-and-mortar stores and e-commerce platforms, delivering seasonal collections, limited-edition releases and signature scent lines.

Founded in 1990 as part of Limited Brands (now L Brands), Bath & Body Works opened its first store in New Albany, Ohio, and quickly expanded across the United States.